4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-22-000007
CFO and Treasurer sold 2,225 shares at $44.75 ($99,569)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Krognes Steve E. CFO and Treasurer | 2022-01-05 | Sale | −2,225 | $44.75 | $99,569 | 124,077 | D |
| Open-market sales · 2,225 sh · avg $44.75 · $99,569 | |||||||
Loading xslF345X03/wf-form4_164159675294746.xml…